Regeneron and BioMed Rlty. Trust host ribbon-cutting for 229,000 s/f
October 23, 2009 - Spotlights
The $115 million investment in this complex, one of the largest corporate facilities to be built in Westchester County in recent years, represents a major commitment to the county and state by Regeneron and BioMed and solidifies The Landmark at Eastview as the region's premier life science campus.
"Our new headquarters and research facility at Landmark provide the efficient and modern facilities we need for our operations," said Dr. Schleifer. "BioMed has provided the critical facilities and expertise that have effectively supported our expansion in Westchester County. We are also pleased to share this celebration with our neighbors and civic leaders in the county, our corporate home since 1989 and an area that cultivates important scientific development."
The completion of this new facility is the culmination of a successful economic development effort involving the Empire State Development Corp., the Westchester County Industrial Development Agency and the Town of Greenburgh. Regeneron and BioMed broke ground on the two new build-to-suit buildings, comprising approximately 230,000 s/f, in April 2007. William A. Berry & Son, Inc. of Danvers, Mass., was the construction manager for the project.
Regeneron, a fully integrated biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of serious medical conditions including cancer, gout, and retinal and other diseases, will use the new facilities for its research and development laboratories, clinical development staff, corporate headquarters and administrative offices. With the two new buildings, Regeneron now occupies approximately 390,000 s/f in four buildings on the 116-acre Landmark campus. Regeneron, which had just four employees when it opened its research laboratories at The Landmark at Eastview in 1989, now has over 1,000 employees. Regeneron's full-scale manufacturing facility is in Rensselaer, New York.
In his comments at the ribbon cutting, Griffin said, "Regeneron has been a model partner for BioMed throughout our association. Their long history of scientific advancements in discovering drug candidates for treatment of serious conditions is a template for success in life science research and development. We look forward to many more years of supporting Regeneron's real estate needs in Westchester County."
"For more than two decades Regeneron has discovered, developed, and commercialized medicines for the treatment of serious medical conditions right here in New York," said Empire State Development Chairman and CEO designate, Dennis Mullen. "They have invested millions into the New York economy, and employ more than 1,000, with nearly 700 jobs in Tarrytown and more than 200 in Rensselaer. Today's opening of their new headquarters means we are securing those jobs for New York State. Regeneron is an example of the type of investment which will foster sustainable growth, create jobs, revive our economy and expand opportunities for all New Yorkers."
The new facilities offer environmentally friendly design features, including a white roof to reflect heat, a high efficiency HVAC system, building layouts for laboratories and offices to maximize day lighting, a courtyard located between buildings that maximizes permeable surfaces to reduce water runoff, and extensive use of sustainable materials such as bamboo flooring and low volatility organic compounds. In addition, as part of The Landmark at Eastview campus, employees are provided complimentary shuttle service to the North White Plains and Tarrytown Metro North Stations and convenient access to other public transportation.
The Landmark at Eastview is one of the largest privately-owned, multi-tenant science parks in New York State. The 116-acre campus consists of eight buildings and over 1.1 million rentable square feet of research and development facilities and high-tech office space. Construction of a third lab-ready building was initiated and completed concurrently with the core and shell construction for Regeneron's two new buildings.